CLINICAL_TRIALS
trial_result
· 2011-01-10
Clinical Trial Update: Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older [Phase 3]
Summary
This Phase 3 trial evaluated zoledronic acid for preventing bone loss in postmenopausal women with osteopenia and has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Osteopenia | Phase 3 | Status: COMPLETED | Results posted: 2011-01-10